Fangfei Li

1.7k total citations · 1 hit paper
41 papers, 1.3k citations indexed

About

Fangfei Li is a scholar working on Oncology, Immunology and Neurology. According to data from OpenAlex, Fangfei Li has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 9 papers in Immunology and 7 papers in Neurology. Recurrent topics in Fangfei Li's work include Parkinson's Disease Mechanisms and Treatments (6 papers), Neurological disorders and treatments (4 papers) and Immune Cell Function and Interaction (4 papers). Fangfei Li is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (6 papers), Neurological disorders and treatments (4 papers) and Immune Cell Function and Interaction (4 papers). Fangfei Li collaborates with scholars based in China, Hong Kong and United Kingdom. Fangfei Li's co-authors include F. Richard Keene, J. Grant Collins, Ge Zhang, Aiping Lü, Tao Feng, Shun Yu, Xuemei Wang, Xiaoqiu Wu, Chao Liang and Yongshu Li and has published in prestigious journals such as Chemical Society Reviews, Nature Communications and Cancer Research.

In The Last Decade

Fangfei Li

38 papers receiving 1.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation

2023 113 citations Ting Yu, Junjie Lu et al. International Journal of Biological Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fangfei Li China	15	477	440	265	158	157	41	1.3k
Fuli Wang China	27	252 0.5×	979 2.2×	258 1.0×	48 0.3×	241 1.5×	116	2.1k
Renata Jaskula‐Sztul United States	27	508 1.1×	1.0k 2.4×	87 0.3×	154 1.0×	120 0.8×	67	1.9k
Yōko Matsumoto Japan	25	256 0.5×	1.1k 2.5×	139 0.5×	41 0.3×	98 0.6×	156	2.1k
Wenyu Li China	24	341 0.7×	1.7k 3.9×	187 0.7×	77 0.5×	63 0.4×	60	2.6k
Clemens Zwergel Italy	27	293 0.6×	1.1k 2.5×	388 1.5×	40 0.3×	90 0.6×	69	1.9k
Jan Hraběta Czechia	23	606 1.3×	1.6k 3.8×	193 0.7×	174 1.1×	117 0.7×	53	2.5k
Ennio Cavalletti Italy	19	675 1.4×	478 1.1×	188 0.7×	88 0.6×	127 0.8×	35	1.5k
Zhengzheng Li China	23	401 0.8×	755 1.7×	330 1.2×	24 0.2×	89 0.6×	67	1.8k
Xiaowei Dong United States	15	349 0.7×	791 1.8×	119 0.4×	37 0.2×	172 1.1×	39	1.9k
Yoshihisa Namiki Japan	19	247 0.5×	486 1.1×	137 0.5×	62 0.4×	105 0.7×	43	1.5k

Countries citing papers authored by Fangfei Li

Since Specialization

Citations

This map shows the geographic impact of Fangfei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangfei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangfei Li more than expected).

Fields of papers citing papers by Fangfei Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangfei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangfei Li. The network helps show where Fangfei Li may publish in the future.

Co-authorship network of co-authors of Fangfei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Fangfei Li. A scholar is included among the top collaborators of Fangfei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangfei Li. Fangfei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luo, Han-Yan, Xiang Xiao, Fangfei Li, et al.. (2025). Impact of pectin structural diversity on gut microbiota: A mechanistic exploration through in vitro fermentation. Carbohydrate Polymers. 355. 123367–123367. 4 indexed citations

Li, Fangfei, et al.. (2025). Urine Output as a Novel Predictor for In‐Hospital Mortality in Acute Pulmonary Embolism Patients: Training With the MIMIC Database and Validation With Independent Cohort. Cardiovascular Therapeutics. 2025(1). 7907049–7907049. 1 indexed citations

Lü, Aiping, et al.. (2025). Abstract A021: Cancer-associated fibroblast-derived CXCL12 as a potential therapeutic target for pancreatic ductal adenocarcinoma immunotherapy. Cancer Research. 85(5_Supplement). A021–A021.

Sun, Yangying, et al.. (2025). The impact of Pleurotus eryngii on myofibrillar protein: Physicochemical properties and structural alterations in quick-frozen pork patties during freeze-thaw cycles. Food Chemistry X. 31. 103064–103064. 1 indexed citations

Liu, Yang, et al.. (2024). Inflammatory Processes: Key Mediators of Oncogenesis and Progression in Pancreatic Ductal Adenocarcinoma (PDAC). International Journal of Molecular Sciences. 25(20). 10991–10991. 2 indexed citations

Sheng, Yalan, et al.. (2024). Abstract 5459: Inflammatory gene-based subtyping of osteosarcoma patients reveals the association of inflammation in tumor microenvironment with better survival. Cancer Research. 84(6_Supplement). 5459–5459. 1 indexed citations

Wan, Qi, et al.. (2024). Therapeutic potential of flavonoids from traditional Chinese medicine in pancreatic cancer treatment. Frontiers in Nutrition. 11. 1477140–1477140. 7 indexed citations

Chen, Zhen, et al.. (2023). Mechanistic Insights into the Roles of the IL-17/IL-17R Families in Pancreatic Cancer. International Journal of Molecular Sciences. 24(17). 13539–13539. 4 indexed citations

Yu, Ting, Junjie Lu, Xiaohu Ouyang, et al.. (2023). Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation. International Journal of Biological Sciences. 19(5). 1471–1489. 113 indexed citations breakdown →

10.

Cao, Shuang‐Shuang, et al.. (2022). Prevalence of axial postural abnormalities and their subtypes in Parkinson’s disease: a systematic review and meta-analysis. Journal of Neurology. 270(1). 139–151. 12 indexed citations

11.

Li, Fangfei, Yusha Cui, Rui Yan, Shuang‐Shuang Cao, & Tao Feng. (2022). Prevalence of lower urinary tract symptoms, urinary incontinence and retention in Parkinson's disease: A systematic review and meta-analysis. Frontiers in Aging Neuroscience. 14. 977572–977572. 13 indexed citations

12.

Li, Fangfei, et al.. (2021). School-Aged Students’ Sustainable Online Learning Engagement during COVID-19: Community of Inquiry in a Chinese Secondary Education Context. Sustainability. 13(18). 10147–10147. 24 indexed citations

13.

Li, Fangfei, et al.. (2021). ACY1 regulating PTEN/PI3K/AKT signaling in the promotion of non-small cell lung cancer progression. Annals of Translational Medicine. 9(17). 1378–1378. 12 indexed citations

14.

Sun, Meiheng, Xiaoqiu Wu, Yuanyuan Yu, et al.. (2020). Disorders of Calcium and Phosphorus Metabolism and the Proteomics/Metabolomics-Based Research. Frontiers in Cell and Developmental Biology. 8. 576110–576110. 49 indexed citations

15.

Yuan, Shiwen, Dongying Chen, Fangfei Li, et al.. (2019). miR-98 Modulates Cytokine Production from Human PBMCs in Systemic Lupus Erythematosus by Targeting IL-6 mRNA. Journal of Immunology Research. 2019. 1–11. 29 indexed citations

16.

Liang, Chao, Jie Li, Cheng Lü, et al.. (2019). HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis. Nature Communications. 10(1). 4579–4579. 36 indexed citations

17.

Li, Fangfei & Muthu Periasamy. (2019). Skeletal muscle inefficiency protects against obesity. Nature Metabolism. 1(9). 849–850. 4 indexed citations

18.

Li, Yongshu, Fangfei Li, Feng Jiang, et al.. (2016). A Mini-Review for Cancer Immunotherapy: Molecular Understanding of PD-1/PD-L1 Pathway & Translational Blockade of Immune Checkpoints. International Journal of Molecular Sciences. 17(7). 1151–1151. 124 indexed citations

19.

Tang, Chun, et al.. (2014). Prolactin increases tumor necrosis factor alpha expression in peripheral CD14 monocytes of patients with rheumatoid arthritis. Cellular Immunology. 290(1). 164–168. 17 indexed citations

20.

Cai, Xiaoyan, et al.. (2012). Helper T cell 17-regulatory T cell equilibrium in patients with systemic lupus erythematosus. 18(6). 468–472. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact